Male pattern baldness has plagued many men.
Samumed, a pharmaceutical research company, has come to the rescue.
It revealed that it recently completed a successful trial of a drug that reverses hair loss in men.
The drug, called SM04554, is designed to help treat male pattern baldness, which is common in both men and women, according to a report published in Dailymail.
Men between the ages of 18 and 55 were the subjects of the trial.
Researchers said: 'SM04554 appears to be safe, well-tolerated, and potentially efficacious.’, concluded the report.
&uuid=(email))